Table 2.
Association between the α-methylacyl-CoA racemase (AMACR) expression and tumour features
| AMACR expression | p Value | ||
|---|---|---|---|
| Low expression | High expression | ||
| Progression of cirrhosis | |||
| Normal/early-stage | 44 (57%) | 33 (43%) | |
| Advanced-stage | 51 (63%) | 30 (37%) | NS |
| Dissemination to regional lymph nodes | |||
| Yes | 7 (100%) | 0 (0%) | |
| No | 88 (58%) | 63 (42%) | 0.042* |
| Tumour capsule | |||
| Present | 64 (55%) | 53 (45%) | |
| Absent | 31 (76%) | 10 (24%) | 0.026* |
| Tumour boundaries | |||
| Distinct | 83 (58%) | 60 (42%) | |
| Indistinct | 12 (86%) | 2 (14%) | 0.049* |
| Portal vein tumour thrombosis(PVTT) | |||
| Yes | 33 (79%) | 9 (21%) | |
| No | 62 (53%) | 54 (47%) | 0.006** |
| Intraoperative ascites | |||
| Yes | 25 (70%) | 11 (30%) | |
| No | 70 (57%) | 52 (43%) | NS |
*p<0.05; **p<0.01.
NS, no statistical significance.